St. Jude Medical (St. Paul) in early May reported FDA and CE-marking approvals for its newest pacemaker family and first implants of the devices. The company said that the Zephyr pacemaker is designed to save clinic time by automatically performing all follow-up testing before the patient arrives in the clinic.